Trials / Completed
CompletedNCT03696303
Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 959 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 31 Days – 5 Years
- Healthy volunteers
- Accepted
Summary
This prospective case-control study aims to evaluate the utility and establish laboratory thresholds for a multi-serotype urine antigen test for the diagnosis of pneumococcal community acquired pneumonia in children 5 years of age or younger in Guatemala.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Urinary antigen detection assay | Screening for Ag level in S. pneumoniae urinary antigen detection assay. |
Timeline
- Start date
- 2019-03-13
- Primary completion
- 2022-03-31
- Completion
- 2022-03-31
- First posted
- 2018-10-04
- Last updated
- 2022-05-04
Locations
3 sites across 1 country: Guatemala
Source: ClinicalTrials.gov record NCT03696303. Inclusion in this directory is not an endorsement.